IPO
This Week's IPO Class Delivered A Split Verdict
The same week produced a 19% pop for Ligent, a 12% decline for Electra Therapeutics, and a pulled listing for Bamboo Insurance -- evidence the 2026 IPO window is open but pricing power now depends entirely on the individual deal.
DEEP DIVE